Form 144/A Axsome Therapeutics, Filed by: Jacobson Mark L.
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Axsome starts Phase 3 trial of solriamfetol for adolescent ADHD
- Advanced Gold Exploration Announces Initial Issuance Under Option Agreement
- Banco Itaú Chile Schedules Second Quarter 2026 Financial Results Conference Call
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
